Matthew Davis
Chief Operating Officer at TIZIANA LIFE SCIENCES LTD
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gabriele Cerrone | M | 52 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 26 years |
| John Brancaccio | M | 76 |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 4 years |
| Willy Simon | M | 72 |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 9 years |
| Martin S. Dorph | M | - |
Temple University (Pennsylvania)
| 29 years |
| Richard J. Fox | M | - |
Temple University (Pennsylvania)
| - |
| Keeren Shah | F | 47 |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 4 years |
| Michael L. Browne | M | 77 |
Temple University (Pennsylvania)
| - |
| Tsan Chien Chen | M | - |
Temple University (Pennsylvania)
| - |
| Kenneth J. Blank | M | - |
Temple University (Pennsylvania)
| - |
| John William Smagula | M | 54 |
Temple University (Pennsylvania)
| 21 years |
| Chidiebere Uzoije | M | - |
Temple University (Pennsylvania)
| 25 years |
| Bret Perkins | M | - |
Temple University (Pennsylvania)
| - |
| Bruce K. Fenton | M | - |
Temple University (Pennsylvania)
| - |
| Brian Bollwage | M | - |
Temple University (Pennsylvania)
| - |
| Joel C. Rosenfeld | M | - |
Temple University (Pennsylvania)
| - |
| Gerard J Criner | M | - |
Temple University (Pennsylvania)
| - |
| Vaseem Palejwala | M | - | 7 years | |
| Shannon M. Wong | M | - |
Temple University (Pennsylvania)
| - |
| Judith Felgoise | F | - |
Temple University (Pennsylvania)
| - |
| John Contoudis | M | - |
Temple University (Pennsylvania)
| - |
| Edward Rudolph | M | - |
Temple University (Pennsylvania)
| - |
| Teresa Soufas | F | - |
Temple University (Pennsylvania)
| - |
| Robert Stroker | M | - |
Temple University (Pennsylvania)
| - |
| Sandra Harmon-Weiss | F | - |
Temple University (Pennsylvania)
| - |
| Paul Rardin | M | - |
Temple University (Pennsylvania)
| - |
| Sophia Lee | F | - |
Temple University (Pennsylvania)
| - |
| Paul Spencer | M | - | 2 years | |
| Kathryn R. Doyle | M | - |
Temple University (Pennsylvania)
| - |
| Yuan Shi | M | - |
Temple University (Pennsylvania)
| - |
| John Timothy Nosek | M | - |
Temple University (Pennsylvania)
| - |
| Jay H. Shah | M | 55 |
Temple University (Pennsylvania)
| - |
| Nelson Díaz | M | 76 |
Temple University (Pennsylvania)
| - |
| Alan M. Cohen | M | 73 |
Temple University (Pennsylvania)
| - |
| Sandra C. Cottrell | M | 75 |
Temple University (Pennsylvania)
| - |
| Jon Boscia | M | 71 |
Temple University (Pennsylvania)
| - |
| Lonnie Moulder | M | 66 |
Temple University (Pennsylvania)
| - |
| Jane Scaccetti | F | 69 |
Temple University (Pennsylvania)
| 17 years |
| David R. Devereaux | M | - |
Temple University (Pennsylvania)
| - |
| Joseph Coradino | M | 72 |
Temple University (Pennsylvania)
| - |
| Reza Fassihi | M | 72 |
Temple University (Pennsylvania)
| 32 years |
| Jules S. Jacob | M | - |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | - |
| Najib Babul | M | - |
Temple University (Pennsylvania)
| - |
| Patrick J. O'Connor | M | - |
Temple University (Pennsylvania)
| - |
| Joseph Marshall | M | 71 |
Temple University (Pennsylvania)
| 23 years |
| Philip E. Garber | M | - |
Temple University (Pennsylvania)
| - |
| Robert Dettery | M | - |
Temple University (Pennsylvania)
| - |
| Reese Timothy | M | - |
Temple University (Pennsylvania)
| - |
| John J. Friel | M | - |
Temple University (Pennsylvania)
| - |
| Sydney D. Finkelstein | M | - |
Temple University (Pennsylvania)
| - |
| Joseph Vassalluzzo | M | 75 |
Temple University (Pennsylvania)
| - |
| Langley Spurlock | M | - |
Temple University (Pennsylvania)
| - |
| Michael E. Lusty | M | 61 |
Temple University (Pennsylvania)
| - |
| William Clementi | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kunwar Shailubhai | M | 67 |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 14 years |
| Hana Malik | M | - |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 9 years |
| Neil Graham | M | 65 |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 80.36% |
| Bermuda | 11 | 19.64% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthew Davis
- Personal Network
